ロード中...
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
The optimal sequence of systemic chemotherapy in metastatic breast cancer (MBC) is unknown. We report the case of a woman who was successfully treated with nanoparticle albumin-bound (nab)-paclitaxel for triple negative MBC in our institution. In November 2008, a 48-year-old woman underwent surgical...
保存先:
| 出版年: | Anticancer Drugs |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243802/ https://ncbi.nlm.nih.gov/pubmed/25115342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000159 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|